HIGH-GRADE SEROUS OVARIAN CANCER
Clinical trials for HIGH-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a vaccine called DCP-001 in 17 women with a serious type of ovarian cancer who had already completed standard treatment. The goal was to see if the vaccine is safe and can boost the immune system to recognize and fight cancer cells. Researchers measu…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: University Medical Center Groningen • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:28 UTC
-
New drug cocktail shows promise for tough ovarian cancers
Disease control CompletedThis study tested a combination of two drugs, AZD6738 and olaparib, in 123 women with recurrent ovarian cancer. The goal was to see if the combo is safe and how well it shrinks tumors or delays cancer growth. Participants had either platinum-sensitive or platinum-resistant cancer…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called RP-6306 in 28 people with advanced cancer that could not be cured. The goal was to see if adding RP-6306 to standard treatment helps shrink tumors and is safe. Researchers also looked for specific biomarkers to see if some patients respond bett…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cancer drug karonudib tested for first time in humans
Disease control CompletedThis early-phase trial tested a new drug, Karonudib, in 63 people with advanced solid tumors that had not responded to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers also looked at how the drug moves through the body and any …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated Jun 26, 2026 15:08 UTC
-
Blood clues: new study looks at tumor cells in ovarian cancer
Knowledge-focused CompletedThis study looked at 30 women with advanced ovarian cancer to count and examine tumor cells found in their blood. The goal was to see if these cells could help predict how the disease might progress or respond to treatment. The results may lead to better ways to monitor the disea…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC